Rafael Canton

Prof. Dr. Rafael Canton

orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2021 in Clinical Microbiology Reviews
Verified
Journal Article
Closed access
FBFernando Baquero
Fernando Baquero
JMJose Martinez
Jose Martinez
VLV. F. Lanza
V. F. Lanza
JRJerónimo Rodríguez-Beltrán
Jerónimo Rodríguez-Beltrán
JGJ. C. Galán
J. C. Galán
TCT. M. Coque
T. M. Coque
Evolution is the hallmark of life. Descriptions of the evolution of microorganisms have provided a wealth of information, but knowledge regarding “what happened” has precluded a deeper understanding of “how” evolution has proceeded, as in the case of antimicrobial resistance.

17 April 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
TCTeresa M. Coque
Teresa M. Coque
RCRafael Canton
Rafael Canton
APAna Elena Pérez-Cobas
Ana Elena Pérez-Cobas
MFMiguel D. Fernández-De-Bobadilla
Miguel D. Fernández-De-Bobadilla
FBFernando Baquero
Fernando Baquero
Antimicrobial resistance (AMR) is one of the Global Health challenges of the 21st century. The inclusion of AMR on the global map parallels the scientific, technological, and organizational progress of the healthcare system and the socioeconomic changes of the last 100 years. Available knowledge about AMR has mostly come from large healthcare institutions in high-income countries and is scattered in studies across various fields, focused on patient safety (infectious diseases), transmission pathways and pathogen reservoirs (molecular epidemiology), the extent of the problem at a population level (public health), their management and cost (health economics), cultural issues (community psychology), and events associated with historical periods (history of science). However, there is little dialogue between the aspects that facilitate the development, spread, and evolution of AMR and various stakeholders (patients, clinicians, public health professionals, scientists, economic sectors, and funding agencies). This study consists of four complementary sections. The first reviews the socioeconomic factors that have contributed to building the current Global Healthcare system, the scientific framework in which AMR has traditionally been approached in such a system, and the novel scientific and organizational challenges of approaching AMR in the fourth globalization scenario. The second discusses the need to reframe AMR in the current public health and global health contexts. Given that the implementation of policies and guidelines are greatly influenced by AMR information from surveillance systems, in the third section, we review the unit of analysis (“the what” and “the who”) and the indicators (the “operational units of surveillance”) used in AMR and discuss the factors that affect the validity, reliability, and comparability of the information to be applied in various healthcare (primary, secondary, and tertiary), demographic, and economic contexts (local, regional, global, and inter-sectorial levels). Finally, we discuss the disparities and similarities between distinct stakeholders’ objectives and the gaps and challenges of combatting AMR at various levels. In summary, this is a comprehensive but not exhaustive revision of the known unknowns about how to analyze the heterogeneities of hosts, microbes, and hospital patches, the role of surrounding ecosystems, and the challenges they represent for surveillance, antimicrobial stewardship, and infection control programs, which are the traditional cornerstones for controlling AMR in human health.

11 May 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
AVAida Alonso-Del Valle
Aida Alonso-Del Valle
RLRicardo León-Sampedro
Ricardo León-Sampedro
JRJerónimo Rodríguez-Beltrán
Jerónimo Rodríguez-Beltrán
JDJavier DelaFuente
Javier DelaFuente
MHMarta Hernández-García
Marta Hernández-García
AMAlvaro San Millán
Alvaro San Millán
Plasmid persistence in bacterial populations is strongly influenced by the fitness effects associated with plasmid carriage. However, plasmid fitness effects in wild-type bacterial hosts remain largely unexplored. In this study, we determined the fitness effects of the major antibiotic resistance plasmid pOXA-48_K8 in wild-type, ecologically compatible enterobacterial isolates from the human gut microbiota. Our results show that although pOXA-48_K8 produced an overall reduction in bacterial fitness, it produced small effects in most bacterial hosts, and even beneficial effects in several isolates. Moreover, genomic results showed a link between pOXA-48_K8 fitness effects and bacterial phylogeny, helping to explain plasmid epidemiology. Incorporating our fitness results into a simple population dynamics model revealed a new set of conditions for plasmid stability in bacterial communities, with plasmid persistence increasing with bacterial diversity and becoming less dependent on conjugation. These results help to explain the high prevalence of plasmids in the greatly diverse natural microbial communities.

16 March 2022 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
CGChristian G. Giske
Christian G. Giske
JTJohn Turnidge
John Turnidge
RCRafael Canton
Rafael Canton
GKGunnar Kahlmeter
Gunnar Kahlmeter
The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is an international susceptibility testing committee, organized by the European Society for Clinical Microbiology and Infectious Diseases (ESCMID) and functioning as the breakpoint advisory committee of the European Medicines Agency (EMA). The original remit of EUCAST was to harmonize European clinical breakpoints, but very soon, the activities expanded beyond the borders of Europe and included newly licensed agents in Europe.

14 June 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
MBMabel Budia-Silva
Mabel Budia-Silva
TKTomislav Kostyanev
Tomislav Kostyanev
SAStefany Ayala-Montaño
Stefany Ayala-Montaño
JAJose Bravo-Ferrer Acosta
Jose Bravo-Ferrer Acosta
MGMaria Garcia-Castillo
Maria Garcia-Castillo
SRSandra Reuter
Sandra Reuter
Carbapenem-resistant Klebsiella pneumoniae (CRKP) are of particular concern due to the spread of antibiotic resistance genes associated with mobile genetic elements. In this study, we collected 687 carbapenem-resistant strains recovered among clinical samples from 41 hospitals in nine Southern European countries (2016-2018). We identified 11 major clonal lineages, with most isolates belonging to the high-risk clones ST258/512, ST101, ST11, and ST307. blaKPC-like was the most prevalent carbapenemase-encoding gene (46%), with blaOXA-48 present in 39% of isolates. Through the combination and comparison of this EURECA collection with the previous EuSCAPE collection (2013-2014), we investigated the spread of high-risk clones circulating in Europe exhibiting regional differences. We particularly found blaKPC-like ST258/512 in Greece, Italy, and Spain, blaOXA-48 ST101 in Serbia and Romania, blaNDM ST11 in Greece, and blaOXA-48-like ST14 in Türkiye. Genomic surveillance across Europe thus provides crucial insights for local risk mapping and informs necessary adaptions for implementation of control strategies.

29 March 2021 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
RLRicardo León-Sampedro
Ricardo León-Sampedro
JDJavier DelaFuente
Javier DelaFuente
CDCristina Díaz-Agero
Cristina Díaz-Agero
TCThomas Crellen
Thomas Crellen
PMPatrick Musicha
Patrick Musicha
ÁMÁlvaro San Millán
Álvaro San Millán